Lapatinib/Trastuzumab Regimen

Preferred Label : Lapatinib/Trastuzumab Regimen;

NCIt synonyms : Lapatinib/Trastuzumab; Lapatinib Plus Trastuzumab; Lapatinib Trastuzumab; Lapatinib Trastuzumab Regimen; Lapatinib-Trastuzumab Regimen;

NCIt related terms : Lapatinib and Trastuzumab; Lapatinib and Trastuzumab-zerc; Lapatinib and Trastuzumab-qyyp; Lapatinib and Trastuzumab-herw; Lapatinib and Trastuzumab-dttb; Lapatinib and Trastuzumab-dkst; Lapatinib and Trastuzumab-pkrb; Lapatinib and Trastuzumab-anns;

NCIt definition : A regimen consisting of lapatinib and trastuzumab that can be used for the treatment of bone, breast, and colorectal cancers, appendiceal adenocarcinoma, and anaplastic carcinoma.;

NCIt note : Source: NCCN Guidelines 2017;

Codes from synonyms : 6946; 128830; 129121; 129024; 128927; 129412; 129315; 129218;

Details

Origin ID

C138040;

UMLS CUI

C1541246;

Est indiqué pour
- HER2-Positive Breast Carcinoma [NCIt concept]
- HER2-positive metastatic breast cancer [Indication]
- breast cancer [MeSH concept]
- breast cancer whose tumours overexpress HER2 with hormone receptor-negative metastatic disease that has progressed [Indication]
Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Lapatinib Ditosylate [NCIt concept]
- Trastuzumab [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients